INVEST Precision Medicine conference kicks off today. Register now to be part of the conversation.

INVESTING Precision Medicine, a June 9-11 online conference that brings together a broad range of industry experts in computational genomics and bioinformatics in pediatrics with biotech and patient advocacy groups seeking to improve diversity in drug development.

View the agenda for Wednesday 9 June here:

Pediatrics and Precision Medicine: 10:30-11:30 ET

A panel of precision medicine experts from pediatric hospitals will participate in a talk highlighting the work being done to improve the way rare diseases and childhood cancer are diagnosed and treated.

Moderator: Samuel Blackman, MD, PhD, Co-Founder and Chief Medical Officer, Day One Biopharmaceuticals @drsam


Josh Bonkowsky, MD, PhD, Medical Director, Primary Children’s Center for Personalized Medicine, Intermountain Healthcare Tomi Pastinen, MD, PhD, Director, Genomic Medicine Center, Children’s Mercy Kansas City Peter White, PhD, Senior Director of The Steve & Cindy Rasmussen Institute of Genomic Medicine, Nationwide Children’s Hospital

Click here to see the rest of the agenda for the week.

How can we improve health equity in precision medicine?

1:00-2:00 PM ET

Targeted therapies for certain cancers to rare diseases offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?

Moderator: Kemi Olugemo, MD, Executive Medical Director, Neurology Clinical Development, Ionis Pharmaceuticals, Inc.

Kate Burke, MD, senior medical advisor, PatientsLikeMe
Elisabeth Heath, MD, director of the Associate Center, Translational Sciences; chairman, multidisciplinary team for genitourinary oncology, Karmanos Cancer Institute
Alyshia Merchant, Founder, Making Lupus Look Good

Pitch Perfect Precision Medicine Part 1: Health IT: 3:30pm-5pm ET

Presentations by an exciting range of technology startups, including:

A biomedical data platform Personalized health approach to weight management Identifying biomarkers in a person’s voice to detect disease Developing microbiome-based solutions

They present companies include:

BioXPlor Intellihealth Vocalis Health PhenoBiome AIQ Solutions

The companies are judged by three judges:

Andrea Jackson, Director, Northpond Ventures Alyssa Jaffee, Partner, 7wire Ventures Taha Jangda, Partner, HealthX Ventures

Photo: SusanneB, Getty Images

Comments are closed.